Use the Search Fields to Find Information
Page 81 of 339
Preliminary Investigation of the Safety of Escalating Cannabinoid Doses in Healthy Dogs
Objective: To determine the safety and tolerability of escalating doses of three cannabis oil formulations, containing predominantly CBD, THC, or CBD and THC (1.5:1) vs. placebo
October 28, 2021
Preliminary in vivo evidence of lower hippocampal synaptic density in cannabis use disorder
Please use this link to access this publication. Abstract Cannabis is one of the most commonly and widely used psychoactive drugs. The rates of cannabis
June 21, 2025
Preliminary assessment of the efficacy, tolerability and safety of a cannabis-based medicine (Sativex) in the treatment of pain caused by rheumatoid arthritis
Abstract Objectives: To assess the efficacy of a cannabis-based medicine (CBM) in the treatment of pain due to rheumatoid arthritis (RA). Methods: We compared a
September 7, 2021
Preliminary assessment of medical cannabis consumption by cancer survivors
Abstract Objectives To assess the motivation of cancer survivors to consume medical cannabis and to assess the patterns of use, perceived efficacy, as well as
July 25, 2025
Preinjury Use of Marijuana and Outcomes in Trauma Patients
Please use this link to access this publication. Abstract Background Recent studies have examined the effects of marijuana in various populations; however, there has been
May 21, 2024
Pregnant Women’s Current and Intended Cannabis Use in Relation to Their Views Toward Legalization and Knowledge of Potential Harm
Please use this link to access this publication. Abstract Objectives: The objective of this study was to investigate pregnant women’s current use of cannabis and
October 7, 2024
Predictors for cannabis cessation during pregnancy: a 10-year cohort study
Abstract The aim of this study is to determine factors associated with cannabis discontinuation, to assess the impact of mental health and addiction interventions on
December 17, 2024
Prediction of Carboxylesterase 1-mediated In Vivo Drug Interaction between Methylphenidate and Cannabinoids using Static and Physiologically Based Pharmacokinetic Models
Abstract The use of cannabis products has increased substantially. Cannabis products have been perceived and investigated as potential treatments for attention-deficit/hyperactivity disorder (ADHD). Accordingly, co-administration
January 17, 2024
Predicting the Potential for Cannabinoids to Precipitate Pharmacokinetic Drug Interactions via Reversible Inhibition or Inactivation of Major Cytochromes
Please use this link to access this publication. ABSTRACT Cannabis is used for both recreational and medicinal purposes. The most abundant constituents are the cannabinoids – cannabidiol (CBD, nonpsychoactive)
October 2, 2025
Predicting Maternal and Infant Tetrahydrocannabinol Exposure in Lactating Cannabis Users: A Physiologically Based Pharmacokinetic Modeling Approach
Abstract A knowledge gap exists in infant tetrahydrocannabinol (THC) data to guide breastfeeding recommendations for mothers who use cannabis. In the present study, a paired
December 7, 2023
Page 81 of 339